Report Detail
Global Transdermal Patch Market Growth 2019-2024
- RnM3002051 |
- 22 February, 2019 |
- Global |
- 133 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
The technical barriers of transdermal patch are high, and the core technology of transdermal patch concentrates in relative large companies. These companies mainly concentrate in USA, Japan and Germany. Japan account for almost 50% of total transdermal patch in 2015, followed by North America with 29% of production share.
In the past few years, the price of transdermal patch has a little change and we expect the price will slightly lower. However, the improvement of energy, transportation costs, employee wages, and equipment depreciation will play a significant role in promoting the cost of transdermal patch.
As the same time, companies are focusing on technological innovation, equipment upgrades, and process improvements, to reduce costs and improve quality. With the snatch for market share in emerging regions, the competition in transdermal patch industry will become more intense.
According to this study, over the next five years the Transdermal Patch market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Transdermal Patch business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Transdermal Patch market by product type, application, key manufacturers and key regions and countries.
This study considers the Transdermal Patch value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Fentanyl Transdermal Patch
Nicotine Transdermal Patch
Buprenorphine Transdermal Patch
Clonidine Transdermal Patch
Oxybutynin Transdermal Patch
Others
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Used to Stop Smoking Cigarettes
Used to Treat High Blood Pressure
Used to Relieve Severe Pain
Used to Treat an Overactive Bladder
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Transdermal Patch consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Transdermal Patch market by identifying its various subsegments.
Focuses on the key global Transdermal Patch manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Transdermal Patch with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Transdermal Patch submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Transdermal Patch Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Transdermal Patch Consumption 2014-2024
- 2.1.2 Transdermal Patch Consumption CAGR by Region
- 2.2 Transdermal Patch Segment by Type
- 2.2.1 Fentanyl Transdermal Patch
- 2.2.2 Nicotine Transdermal Patch
- 2.2.3 Buprenorphine Transdermal Patch
- 2.2.4 Clonidine Transdermal Patch
- 2.2.5 Oxybutynin Transdermal Patch
- 2.2.6 Others
- 2.3 Transdermal Patch Consumption by Type
- 2.3.1 Global Transdermal Patch Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Transdermal Patch Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Transdermal Patch Sale Price by Type (2014-2019)
- 2.4 Transdermal Patch Segment by Application
- 2.4.1 Used to Stop Smoking Cigarettes
- 2.4.2 Used to Treat High Blood Pressure
- 2.4.3 Used to Relieve Severe Pain
- 2.4.4 Used to Treat an Overactive Bladder
- 2.5 Transdermal Patch Consumption by Application
- 2.5.1 Global Transdermal Patch Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Transdermal Patch Value and Market Share by Application (2014-2019)
- 2.5.3 Global Transdermal Patch Sale Price by Application (2014-2019)
3 Global Transdermal Patch by Players
- 3.1 Global Transdermal Patch Sales Market Share by Players
- 3.1.1 Global Transdermal Patch Sales by Players (2017-2019)
- 3.1.2 Global Transdermal Patch Sales Market Share by Players (2017-2019)
- 3.2 Global Transdermal Patch Revenue Market Share by Players
- 3.2.1 Global Transdermal Patch Revenue by Players (2017-2019)
- 3.2.2 Global Transdermal Patch Revenue Market Share by Players (2017-2019)
- 3.3 Global Transdermal Patch Sale Price by Players
- 3.4 Global Transdermal Patch Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Transdermal Patch Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Transdermal Patch Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Transdermal Patch by Regions
- 4.1 Transdermal Patch by Regions
- 4.1.1 Global Transdermal Patch Consumption by Regions
- 4.1.2 Global Transdermal Patch Value by Regions
- 4.2 Americas Transdermal Patch Consumption Growth
- 4.3 APAC Transdermal Patch Consumption Growth
- 4.4 Europe Transdermal Patch Consumption Growth
- 4.5 Middle East & Africa Transdermal Patch Consumption Growth
5 Americas
- 5.1 Americas Transdermal Patch Consumption by Countries
- 5.1.1 Americas Transdermal Patch Consumption by Countries (2014-2019)
- 5.1.2 Americas Transdermal Patch Value by Countries (2014-2019)
- 5.2 Americas Transdermal Patch Consumption by Type
- 5.3 Americas Transdermal Patch Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Transdermal Patch Consumption by Countries
- 6.1.1 APAC Transdermal Patch Consumption by Countries (2014-2019)
- 6.1.2 APAC Transdermal Patch Value by Countries (2014-2019)
- 6.2 APAC Transdermal Patch Consumption by Type
- 6.3 APAC Transdermal Patch Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Transdermal Patch by Countries
- 7.1.1 Europe Transdermal Patch Consumption by Countries (2014-2019)
- 7.1.2 Europe Transdermal Patch Value by Countries (2014-2019)
- 7.2 Europe Transdermal Patch Consumption by Type
- 7.3 Europe Transdermal Patch Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Transdermal Patch by Countries
- 8.1.1 Middle East & Africa Transdermal Patch Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Transdermal Patch Value by Countries (2014-2019)
- 8.2 Middle East & Africa Transdermal Patch Consumption by Type
- 8.3 Middle East & Africa Transdermal Patch Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Transdermal Patch Distributors
- 10.3 Transdermal Patch Customer
11 Global Transdermal Patch Market Forecast
- 11.1 Global Transdermal Patch Consumption Forecast (2019-2024)
- 11.2 Global Transdermal Patch Forecast by Regions
- 11.2.1 Global Transdermal Patch Forecast by Regions (2019-2024)
- 11.2.2 Global Transdermal Patch Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Transdermal Patch Forecast by Type
- 11.8 Global Transdermal Patch Forecast by Application
12 Key Players Analysis
- 12.1 Hisamitsu Pharmaceutical
- 12.1.1 Company Details
- 12.1.2 Transdermal Patch Product Offered
- 12.1.3 Hisamitsu Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Hisamitsu Pharmaceutical News
- 12.2 Novartis
- 12.2.1 Company Details
- 12.2.2 Transdermal Patch Product Offered
- 12.2.3 Novartis Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Novartis News
- 12.3 Johnson & Johnson
- 12.3.1 Company Details
- 12.3.2 Transdermal Patch Product Offered
- 12.3.3 Johnson & Johnson Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Johnson & Johnson News
- 12.4 Teikoku Pharma
- 12.4.1 Company Details
- 12.4.2 Transdermal Patch Product Offered
- 12.4.3 Teikoku Pharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Teikoku Pharma News
- 12.5 Mylan
- 12.5.1 Company Details
- 12.5.2 Transdermal Patch Product Offered
- 12.5.3 Mylan Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Mylan News
- 12.6 Actavis
- 12.6.1 Company Details
- 12.6.2 Transdermal Patch Product Offered
- 12.6.3 Actavis Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Actavis News
- 12.7 Mundipharma
- 12.7.1 Company Details
- 12.7.2 Transdermal Patch Product Offered
- 12.7.3 Mundipharma Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Mundipharma News
- 12.8 Henan Lingrui Pharmaceutical
- 12.8.1 Company Details
- 12.8.2 Transdermal Patch Product Offered
- 12.8.3 Henan Lingrui Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Henan Lingrui Pharmaceutical News
- 12.9 Changzhou Siyao
- 12.9.1 Company Details
- 12.9.2 Transdermal Patch Product Offered
- 12.9.3 Changzhou Siyao Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Changzhou Siyao News
- 12.10 Rfl Pharmaceutical
- 12.10.1 Company Details
- 12.10.2 Transdermal Patch Product Offered
- 12.10.3 Rfl Pharmaceutical Transdermal Patch Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Rfl Pharmaceutical News
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Transdermal Patch . Industry analysis & Market Report on Transdermal Patch is a syndicated market report, published as Global Transdermal Patch Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Transdermal Patch market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
